[Advances in Diagnosis and Treatment of HER2-positive Non-small Cell Lung Cancer].

Abstract excerpt

Lung cancer is the most common malignancy in the world and the leading cause of cancer death. Human epidermal growth factor receptor 2 (HER2) positive non-small cell lung cancer (NSCLC) refers to the NSCLC caused by mutation, amplification or overexpression of the HER2 gene, resulting in its dysfunction. HER2 is the most active receptor in the HER family and can combine with other members to form dimers, which...

Topics

Join the communities discussing this publication.

• Antineoplastic Agents
• Carcinoma, Non-Small-Cell Lung
• Lung Neoplasms
• Mutation
• Protein Kinase Inhibitors